JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


J Am Coll Cardiol, 2006; 48:377-385, doi:10.1016/j.jacc.2006.02.069 (Published online 22 June 2006).
© 2006 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
j.jacc.2006.02.069v1
48/2/377    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Larche, J.
Right arrow Articles by Neviere, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Larche, J.
Right arrow Articles by Neviere, R.

PRECLINICAL STUDIES

Inhibition of Mitochondrial Permeability Transition Prevents Sepsis-Induced Myocardial Dysfunction and Mortality

Jérome Larche, MD*,{dagger}, Steve Lancel, PhD*,{dagger}, Sidi Mohamed Hassoun*,{dagger}, Raphael Favory, MD*,{dagger}, Brigitte Decoster, PhD*,{dagger}, Philippe Marchetti, MD, PhD{ddagger}, Claude Chopin, MD* and Remi Neviere, MD, PhD*,{dagger},*

* EA 2689, Université de Lille 2
{dagger} Département de Physiologie
{ddagger} INSERM U459, Faculté de Médecine 1, Lille, France

Manuscript received November 9, 2005; revised manuscript received February 17, 2006, accepted February 28, 2006.

* Reprint requests and correspondence: Dr. Remi Neviere, Département de Physiologie, Faculté de Médecine 1, Place Verdun, Lille 59045 Lille, France (Email: rneviere{at}univ-lille2.fr).

OBJECTIVES: The purpose of this study was to test whether mitochondrial dysfunction is causative of sepsis sequelae, a mouse model of peritonitis sepsis induced by cecal ligation and perforation. Inhibition of mitochondrial permeability transition was achieved by means of pharmacological drugs and overexpression of the antiapoptotic protein B-cell leukemia (Bcl)-2.

BACKGROUND: Sepsis is the leading cause of death in critically ill patients and the predominant cause of multiple organ failure. Although precise mechanisms by which sepsis leads to multiple organ dysfunction are unknown, growing evidence suggests that perturbations of key mitochondrial functions, including adenosine triphosphate production, Ca2+ homeostasis, oxygen-derived free radical production, and permeability transition, might be involved in sepsis pathophysiology.

METHODS: Heart and lung functions were evaluated respectively by means of isolated heart preparation, bronchoalveolar lavage fluid protein concentration, lung wet/dry weight ratio, lung homogenate myeloperoxidase activity, and histopathologic grading. Respiratory fluxes, calcium uptake, and membrane potential were evaluated in isolated heart mitochondria.

RESULTS: Peritonitis sepsis induced multiple organ dysfunction, mitochondrial abnormalities, and increased mortality rate, which were reduced by pharmacological inhibition of mitochondrial transition by cyclosporine derivatives and mitochondrial Bcl-2 overexpression.

CONCLUSIONS: Our study provides strong evidence that mitochondrial permeability transition plays a critical role in septic organ dysfunction. These studies demonstrate that mitochondrial dysfunction in sepsis is causative rather than epiphenomenal and relevant in terms of vital organ function and outcome. Regarding the critical role of heart failure in the pathophysiology of septic shock, our study also indicates a potentially new therapeutic approach for treatment of sepsis syndrome.

Abbreviations and Acronyms
  BALF = bronchoalveolar lavage fluid
  Bcl = B-cell leukemia
  CLP = cecal ligation and puncture
  CsA = cyclosporine A
  {Delta}{psi}m = mitochondrial transmembrane potential
  MPO = myeloperoxidase
  NIM811 = N-methyl-4-isoleucine cyclosporine
  RCR = respiratory control ratio
  TNF = tumor necrosis factor
  TPP+ = tetraphenylphosphonium







HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 2006 by the American College of Cardiology Foundation.